openPR Logo
Press release

Colorectal Cancer Screening Market to Develop Rapidly by 2034

03-21-2025 05:57 AM CET | Chemicals & Materials

Press release from: Exactitude Consultancy

Colorectal Cancer Screening Market to Develop Rapidly by 2034

The Colorectal Cancer Screening Market Is Set To Grow At An Estimated CAGR Of 5.0% From 2025 To 2034, Rising From $18 Billion In 2024 To $28 Billion By 2034.

On March 21, 2025, Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in the production of Colorectal Cancer Screening market goods. The market study excludes key regions that are accelerating marketization. This section also gives the extent of different market segments and applications that could have an impact on the market in the future. Current trends and historical turning points form the basis of the enormous amount of data. The report includes information on market trends and development, growth drivers, emerging technologies, and the investment structure of the Colorectal Cancer Screening market.

Download Full PDF Sample Copy of Market Report @

https://exactitudeconsultancy.com/request-sample/47963

This report is also available in the following languages: Japanese (大腸がんスクリーニング市場), Korea (대장암 검진 시장), china (结直肠癌筛查市场), French (Marché du dépistage du cancer colorectal), German (Markt für Darmkrebsvorsorge), and Italy Markt für Darmkrebsvorsorge), etc.

Key Companies Profiled

Exact Sciences Corporation, Guardant Health, Inc., Cologuard, Siemens Healthineers, Roche Diagnostics, Epi proColon, Freenome Holdings, Inc., Biocept, Inc., Invitae Corporation, OncoOne, Medtronic plc, F. Hoffmann-La Roche AG, Hologic, Inc., Illumina, Inc., Adiana Health

Market Segmentation

By Test Type

- Stool-Based Tests

- Structural Exam Tests

- Imaging Tests

By End User

- Hospitals

- Diagnostic Laboratories

- Home Care Settings

By Age Group

- 45-50 Years

- 51-60 Years

- 61-70 Years

- 71 Years and Above

By Risk Factor

- Average Risk Population

- High-Risk Population

Explore Full Report here:

https://exactitudeconsultancy.com/reports/47963/colorectal-cancer-screening-market

If opting for the Global version of Colorectal Cancer Screening Market; then the below country analysis would be included:

- North America (the USA, Canada, and Mexico)

- Europe (Germany, France, the United Kingdom, Netherlands, Italy, Nordic Nations, Spain, Switzerland, and the Rest of Europe)

- Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, Southeast Asia, and the Rest of APAC)

- South America (Brazil, Argentina, Chile, Colombia, the Rest of the countries, etc.)

- the Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Turkey, Nigeria, South Africa, Rest of MEA)

Buy Now

https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=47963

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Colorectal Cancer Screening market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Colorectal Cancer Screening market.

Get Your Exclusive Offer with up to 30% Discount

https://exactitudeconsultancy.com/check-discount/47963

Reasons To Buy The Colorectal Cancer Screening Market Report:

➼ In-depth analysis of the market on the global and regional levels.

➼ Major changes in market dynamics and competitive landscape.

➼ Segmentation on the basis of type, application, geography, and others.

➼ Historical and future market research in terms of size, share growth, volume, and sales.

➼ Major changes and assessment in market dynamics and developments.

➼ Emerging key segments and regions

➼ Key business strategies by major market players and their key methods

Our team is available 24/7 to assist and support our customers through reliable research.

Customization

-20% free customization.

-Five Countries can be added as per your choice.

-Five Companies can added as per your choice.

-Free customization up to 40 hours.

-Post-sales support for 1 year from the date of delivery.

Other Reports:

https://www.openpr.com/news/3757951/advanced-recycling-technologies-market-likely-to-experience

https://www.openpr.com/news/3760466/chemical-vapour-deposition-cvd-equipment-market-to-develop

https://www.openpr.com/news/3763037/epoxy-curing-agents-market-growth-analysis-and-key-trends

https://www.openpr.com/news/3765594/io-link-market-share-size-price-growth-report-and-forecast

https://www.openpr.com/news/3767767/phase-change-material-market-by-current-industry-status-growth

https://www.openpr.com/news/3770371/tactile-sensor-market-detailed-analysis-and-forecast-up-to-2030

https://www.openpr.com/news/3774827/automotive-haptic-technology-market-exploring-key

https://www.openpr.com/news/3777594/micro-injection-molded-plastic-market-trends-and-industry

https://www.openpr.com/news/3780031/non-woven-adhesives-market-analysis-with-emerging-trends

https://www.openpr.com/news/3782363/automotive-safety-device-sales-market-to-develop-rapidly-by-2030

Explore additional sites:

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://exactitudeconsultancy.com/

About Us:

Exactitude Consultancy is a Market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our professional team works hard to fetch the most authentic research reports backed with impeccable data figures which guarantee outstanding results every time for you. So, whether it is the latest report from the researchers or a custom requirement, our team is here to help you in the best possible way.

Contact us:

Exactitude Consultancy

PHONE NUMBER +1 (704) 266-3234

EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Colorectal Cancer Screening Market to Develop Rapidly by 2034 here

News-ID: 3928355 • Views:

More Releases from Exactitude Consultancy

Cell Therapy Manufacturing Market to Reach USD 28.4 Billion by 2034, Growing at 13.9% CAGR
Cell Therapy Manufacturing Market to Reach USD 28.4 Billion by 2034, Growing at …
Introduction Cell therapy has emerged as a transformative pillar of modern medicine, offering the potential to repair, replace, or regenerate damaged tissues and organs. From CAR-T cell therapies for oncology to stem cell therapies for regenerative medicine, the field is redefining treatment paradigms across oncology, neurology, cardiology, and rare diseases. As clinical pipelines expand and more therapies achieve regulatory approval, demand for efficient and scalable cell therapy manufacturing has surged. Specialized technologies
Despite safety concerns, adavosertib exhibits early antitumor activity in uterine serous carcinoma
Despite safety concerns, adavosertib exhibits early antitumor activity in uterin …
Uterine serous carcinoma (USC) is a rare but highly aggressive subtype of endometrial cancer, accounting for less than 10% of endometrial cancer cases but contributing to a disproportionately high mortality rate. It is often diagnosed at advanced stages, making it difficult to treat with conventional methods. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72873 In recent years, the treatment landscape has expanded beyond chemotherapy and surgery to include targeted therapies,
Market for Catheter-Related Bloodstream Infections: Overview, Therapies, and Important Players | Exactitude Consultancy
Market for Catheter-Related Bloodstream Infections: Overview, Therapies, and Imp …
Catheter-related bloodstream infections (CRBSIs) are among the most common and serious complications associated with intravascular catheters used in hospitals and long-term care settings. These infections can lead to prolonged hospital stays, increased healthcare costs, and higher mortality rates. With the rising use of central venous catheters, particularly among critically ill patients, oncology cases, and those requiring long-term intravenous therapy, the global demand for effective prevention and treatment solutions is growing
ADC Technology Market to Reach USD 33.7 Billion by 2034, Growing at 13.2% CAGR
ADC Technology Market to Reach USD 33.7 Billion by 2034, Growing at 13.2% CAGR
Introduction Antibody-drug conjugates (ADCs) represent one of the most innovative breakthroughs in oncology, combining the target specificity of monoclonal antibodies with the cytotoxic potency of chemotherapeutic agents. By delivering highly toxic payloads directly to cancer cells, ADCs minimize systemic toxicity and enhance therapeutic efficacy. As cancer incidence rises worldwide and the limitations of conventional chemotherapy become more evident, ADC technology is gaining momentum. With advancements in linker chemistry, payload design, and next-generation

All 5 Releases


More Releases for Colorectal

Metastatic Colorectal Cancer Therapeutics Market - Innovation in Motion: Elevate …
Newark, New Castle, USA: The "Metastatic Colorectal Cancer Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Metastatic Colorectal Cancer Therapeutics Market: https://www.growthplusreports.com/report/metastatic-colorectal-cancer-therapeutics-market/8685 This latest report researches the
Potential Opportunities of Colorectal Cancer Therapeutics Market
The global colorectal cancer therapeutics market size is projected to reach USD 16.58 billion by 2026, owing to the rise in the prevalence of colorectal cancer worldwide. A report by Fortune Business Insights(TM) titled, "Colorectal Cancer Therapeutics Market Size, Share & Industry Analysis, By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Others), By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and
Colorectal Cancer Pipeline Therapeutic Review H1 2017
Colorectal Cancer Pipeline Review H1 2017 provides an overview of the Colorectal Cancer (Oncology) pipeline landscape. Colorectal cancer is cancer that starts in the large intestine (Colorectal). There is no single cause of colorectal cancer. Nearly all colorectal cancers begin as noncancerous (benign) polyps, which slowly develop into cancer. For More on Colorectal Cancer Pipeline Review H1 2017 Report Inquire @ https://goo.gl/1HQ4Fn . Report Description: Pharmaceutical guide Colorectal Cancer - Pipeline Review H1
US Colorectal Cancer Drug Pipeline Analysis
Among all the regions affected with colorectal cancer, the US would continue to account for a giant’s share owing to its huge population base. With regards to rates of increase, it is most likely that the US would witness a modest increase in the prevalence of the disease, mostly as a result of the country having already reached epidemic proportions of the disease. According to estimates, approximately 55,000 people die
Colorectal Cancer - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Colorectal Cancer - Heat Map and Analysis to its growing collection of premium market research reports. Colorectal cancer (CRC), otherwise known as bowel cancer, is a malignancy originating in the colon (the large intestine) or rectum, both of which are located towards the end of the human gastrointestinal tract. It begins as a benign tumor, which is almost always in
Colorectal Cancer Treatment Market- Global Outlook 2024
Colorectal cancer is cancer that starts in the colon or rectum. The colon and the rectum are parts of the large intestine, which is the lower part of the body’s digestive system. The colon absorbs water and nutrients from the food and stores waste matter (stool). Stool moves from the colon into the rectum before it leaves the body. Colorectal cancer often begins as a growth called a polyp, which